SPC191
Rúxólitiníb, eða lyfjafræðilega hæft salt þar af
Status:
AfturkölluðApplication date:
24.4.2017Application published:
15.5.2017
Next due date:
31.12.2026Medicine name:
JakaviMedicine for children:
No
Timeline
Today
24.4.2017Application
15.5.2017Publication
Marketing license
Foreign authorization number:
EU/1/12/773Date:
11.3.2015
Owner
Name:
Incyte Holdings CorporationAddress:
1801 Augustine Cut-Off, Wilmington US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2455382
Deadlines
TypeDeadline until
Type: Frestur til að svara niðurstöðu rannsóknar, fyrsti
Deadline until: 18.03.2021